Lanxess
Lanxess completes acquisition of IPEL
COLOGNE, February 4, 2020
Speciality chemicals company Lanxess has completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The competent anti-trust authorities approved the transaction beginning of January.
IPEL with headquarters in Jarinu, São Paulo, is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million euro range in 2018.
With the acquisition, Lanxess is strengthening its position as one of the world’s leading manufacturers of antimicrobial active ingredients and formulations. In addition to around 100 employees and the production facility, Lanxess has taken over the Brazilian company’s laboratory facilities.
IPEL generates the majority of its sales with biocides and speciality chemicals for the paint and coating industry. The product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.
Lanxess is a leading special-ty chemicals company with sales of EUR7.2 billion in 2018. The company currently has about 15,500 employees in 33 countries and is represented at 58 production sites worldwide.
The core business of Lanxess is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Lanxess is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good. -- Tradearabia News Service
